Introduction

The COVID-19 chest CT scan in severe patients shows more changes in PF, and that change may persist1. PF pathogenesis involves theories of inflammatory response imbalance, extracellular matrix deposition, epithelial-mesenchymal transformation, and oxidative stress. The proliferation of interstitial fibroblasts and fibrotic alterations of interstitial tissues are characteristics of PF2,3,4,5. Repetition of inflammation leads to abnormal expression of the downstream gene and differentiation of fibroblasts, resulting in the repair of excessively fibrous tissue6,7,8. Treatment methods such as glucocorticoids, immunosuppressants, antioxidants, anti-fibrosis medications, etc., delay disease progression and lead to quality of life for patients9,10,11,12,13,14. Therefore, there is an urgent need to find new therapeutic agents to treat PF. Currently, new therapeutic strategies are needed to treat PF.

For thousands of years, Traditional Chinese Medicine (TCM) has long been used for disease prevention and treatment based on systematic approaches15. Research in Chinese medicine and modern medicine concluded that it was an option for treating respiratory diseases. Qilongtian (QLT) is a traditional Chinese medicine prescription with Panax notoginseng, earthworm, and Rhodiola. The main chemical composition of QLT and the role of PF have been shown in Table 116,17,18. In our clinical efficiency observation study showed that QLT reduced inflammatory factor and fiber factor transforming growth factor β (TGF-β) and matrix metalloproteinase-9 (MMP9) to improve anti-infection ability of respiratory tract in chronic obstructive pulmonary disease (COPD) patients19. The animal experimental research indicated that QLT reduced the inflammatory factor interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α) to inhibit the inflammatory reaction of the airway in a pulmonary hypertension rat model20,21. In recent years, Pro. Yi Fu finds that QLT delays the process of PF, improves lung function and life quality of PF patients. However, systematic investigations of the mechanisms by which QLT exerts beneficial effects in PF, including analyses of potential targets, biological processes, and metabolic pathways, are lacking.

Table 1 Properties and potential mechanisms of active compounds in QLT to PF.
Full size table

Multiple signaling pathways contribute to the development of pulmonary fibrosis as the IL-17 signaling pathway plays a direct or indirect role22,23,24. Interleukin 17 (IL-17) is a cytokine mainly derived from Th17 cells. Its main biological effect is the promotion of inflammatory reaction. After IL-17 is attached to the receptor, it exerts biological activity by activating the mitogenic-activated protein kinase18,19. The stimulation of IL-17 signaling pathway promotes the inflammation and fibrosis in lung20,21,22,23,24. One study reported25 that molecular, immunohistochemical, and flow cytometric analyses of human and mouse specimens determine the immune response before collagen deposition. The results showed that PD-1+CD4+ T cells were detected in CD4+ T cells with decreased proliferative capacity and increased expression of transforming growth factor-β (TGF-β)/interleukin-17 (IL-17). PD-1+ T helper 17 cells are the major CD4+ T cell subpopulation expressing TGF-β. PD-1+ CD4+ T cells co-cultured with human lung fibroblasts co-cultured to induce collagen production. Blocking the expression of TGF-β and IL-17 was followed by a reduction in collagen production by fibroblasts. This points to an unrecognized critical role for TGF-β and IL-17 in pulmonary fibrosis. Additionally, genome-scale association studies have demonstrated that the role of the IL-17 signalling pathway in sarcoidosis pulmonary progression is associated with mediation of multiple cytokines26,27,28,29. Analysis of the transcriptome revealed that adaptive immune dysfunction is associated with PF30,31. In the current study, we used QLT to intervene in the mouse PF model, observed the treatment effect, and explore the possible anti-fibrosis mechanism, to provide the experimental basis for QLT in the clinical treatment of PF.

Materials

Experimental animals and feeding

36 male C57BL/6 J mice, SPF grade, 4 weeks old, body weight (20 ± 2) g, (Chengdu Dashuo experimental animal Co., Ltd., Chengdu, China, regular animal No.: SCXK (Sichuan) 2020-030). Laboratory conditions: temperature (22 ± 3 °C), 12 h light–dark cycle. In this study, mice were fed ad libitum and ingested water. All methods were carried out in accordance with the care and use of experimental animals published by the National Institutes of Health and the guidelines of the Animal Care & Welfare Committee of Yunnan University of Chinese Medicine. According to the guidelines for, the mouse experiments have been approved and implemented (Approval Institution: Animal Experiment Ethics Review Committee of Yunnan University of Traditional Chinese, Medicine animal experiment license No.: SYXK (Dian) K2022-0004, animal ethics license No.: R-06202023). All methods are reported in accordance with ARRIVE guidelines.

Experimental drugs

QLT capsule: Panax notoginseng, Earthworm, Rhodiola; 0.4 g per capsule, equivalent to 1.53 g of decoction pieces. The positive drug was selected as pirfenidone (PFD, H20133376, Beijing Contini Pharmaceutical Co., Ltd., Beijing, China). Pirfenidone is a drug for IPF with good anti-inflammatory properties. Hydrochloride Bleomycin (Hanhui Pharmaceutical Co., Ltd. Hangzhou, China) for injection: 15,000 bleomycin units (equivalent to 15 mg)/bottle, purchased from, national medicine permission number (NMPN) H20055883. Before use, add 7.5 ml of normal saline to each bottle to obtain a solution with a concentration of 2 mg/ml.

Modeling and administration

36 mice were randomly divided into control group, model group, QLT low, medium, high administration group and pirfenidone group. Modeling method: the model was made by endotracheal intubation and injection of bleomycin (5 mg/kg)25,26, the control group and model group are gavaged with normal saline, and the QLT low, medium, and high dose groups were gavaged with 0.39 g/kg, 0.78 g/kg and 1.56 g/kg respectively, and Pirfenidone group was gavaged with 0.78 g/kg. The drug was administered at 14 days after modeling, and the materials were taken 21 days after administration.

Invasive pulmonary function test

After administration, mice were anesthetized intraperitoneally with 1% pentobarbital sodium (0.4 g/kg). After fixation, skin preparation, and disinfection, the exposed trachea was gently and passively separated. The trachea was severed horizontally between the tracheal cartilaginous rings. The trachea was lifted after threading, the intubation needle was inserted, and the pulmonary function instrument (model: crfm100, EMMS, UK) was connected, the related indexes of pulmonary function were recorded.

Specimen collection

Three weeks after administration, the middle lobe of the right lung was taken and fixed in tissue fixation solution (Wuhan Servicebio Technology Co., Ltd., Wuhan, PR China) for HE and Masson staining. The left lung was placed in 1.5 ml EP tube and frozen at – 80 °C.

HE staining

Paraffin sections were used for dewaxing, hematoxylin staining, eosin staining, and dehydration sealing. After the above operations, the sections were dried, sealed with neutral gum, microscopically observed, photographed, captured, and analysed.

Masson staining

Paraffin sections were dehydrated, stained with potassium dichromate, ferrochrome, Ponceau red, acid fuchsin, phosphoric acid, and aniline blue, identified, transparent, sealed with neutral glue, observed under a microscope, photographed, and images collected and analyzed.

Hydroxyproline (HYP) detection

The HYP assay was measured with hydroxyproline determination kit (Cat#: A030-2-1, Nanjing Jiancheng Bioengineering Institute), following the product instruction book. The absorbance of each tube was measured with a microplate reader (BioTek SynergyH1, Agilent Technologies, Inc., USA) at a wavelength of 550 nm.

Transcriptome sequencing

The transcriptome sequencing was detected by Metabo-Profile Biotechnology (Shanghai) Co., Ltd., the mRNA with Polya structure in total RNA was enriched by oligo (DT) magnetic beads, and the RNA was interrupted to a fragment with a length of about 300 bp by ion interruption. Using RNA as template, the first strand of cDNA was synthesized with 6-base random primers and reverse transcriptase, and the second strand of cDNA was synthesized with the first strand of cDNA as template. After construction library, the library fragments were enriched by PCR amplification, and then the library was selected according to the fragment size. After RNA extraction, purification, and library construction, these libraries were sequenced by next-generation sequencing (NGS) based on the Illumina sequencing platform.

Elisa

Samples were tested according to the Elisa Kit instructions. The kits were Mouse IL-17 ELISA Kit (PI545, Beyotime), Mouse CCL12 Elisa Kit (SEKM-0164, Solarbio), Mouse FOSL1 Elisa Kit (E03C0735, BlueGene Biotech Co., Ltd.), Mouse MMP9 Elisa Kit (ARG81241, Arigo Biolaboratories Corp.), Mouse CXCL5 Elisa Kit (EMCXCL5, Thermo Fisher), Mouse AREG Elisa Kit (EMAREG, Thermo Fisher). The absorbance was measured, and the concentration was calculated using an enzyme marker (Synergy, BioTek, USA) at 550 nm.

qRT-PCR

The total tissue mRNA was extracted with Invitrogen™ TRIzol™ Reagent (Thermo Fisher Scientific Inc.). The primer sequences were listed in Table 2 and were synthesized by Sangon Biotech (Shanghai) Co., Ltd. The qPCR assay was measured by using Applied Biosystems QuantStudio 5 Real-Time PCR System (A28569, Thermo Fisher Scientific Inc.). The relative mRNA levels of each gene were calculated by using the 2−ΔΔCt method.

Table 2 Sequences of qRT-PCR primers.
Full size table

Immunofluorescence assay

The experimental operation steps of immunofluorescence were as follows. Dewaxing paraffin sections to water, circle, serum blocking, added COL-I antibody: add Goat anti rabbit IgG HRP, After the sections were slightly dried and incubated for 50 min, added Cy3 fluorescence enhancer, added COL-III antibody: add Goat anti rabbit IgG HRP, added FITC fluorescence enhancer, added dropwise into the slice circle and incubated. DAPI staining, autofluorescence quenching, sealing slide, microscopic photography. DAPI staining was blue, COL-I was red, and COL-III was green.

Western blot

Samples were homogenized with Ripa lysate (Cat#: P0013B, Beyotime Biotech-nology), and the total protein concentration was measured with BCA method (Cat#: P0010S, Beyotime Biotechnology). The total protein (20 μg) was separated with 10% SDS–polyacrylamide gel electrophoresis. Then, the protein was transferred to PVDF membrane, blocked with 5% skimmed milk, washed in tris buffer solution containing 0.1% Tween-20 (TBST), and the primary antibody was incubated at 4 ℃ overnight. The primary antibody was used as follows: TGF-β antibody (EPR18163, Cat#: ab215715, Abcam), α-SMA antibody (Cat#: af1032, Affinity), COL-I antibody (EPR22894-89, Cat#: ab260043, Abcam), COL-III antibody (RM1028, Cat#: ab283694, Abcam), TNF-α antibody (EPR20972, Cat#: ab215188, Abcam), β-actin antibody (Cat#:GB12001, Affinity). Goat anti-rabbit IgG (Cat#: bl033a, Biosharp) and Goat anti-mouse IgG (Cat#: bl001a, Biosharp) were used as secondary antibodies. The images were obtained by chemiluminescence systems chemiluminescence systems (GeneGnome XRQ, Syngene, A Division of Synoptics Ltd.), with exposure time of 30–90 s. Use Image J 18.0 software to analyze the gray value of each strip.

Statistical analysis

The experimental data were statistically processed by using SPSS (IBM, Armonk, USA) and GraphPad Prism 10.0 (GraphPad Software, San Diego, CA). The measurement data were expressed by mean ± Standard error of mean (SEM) unless otherwise specified. All endpoints are representative of at least 3 independent experiments and analyzed using one-way ANOVA with the post hoc Bonferroni test. The difference was statistically significant when P < 0.05.

Institutional review board statement

The animal study protocol was approved by the Animal Care & Welfare Committee of Yunnan University of Chinese Medicine (protocol code: R-06202023, June 15th, 2020).

Results

QLT improved the morphology of pulmonary tissue and reduce collagen deposition in PF mice

Bleomycin induced PF in mice is a widely recognized PF model, which lead to pulmonary fibrosis in mice. Based on previous studies showing that mice begin to form collagen on days 3–7 and that inflammation coexists with collagen deposition on day 1438,39, low, medium and high doses of QLT were given to PF mice with intragastric administration within 14–35 days. The morphology of pulmonary tissue was observed by HE staining and Masson staining. Compared with model group, QLT significantly inhibited the infiltration of inflammatory cells and the expansion of alveolar space. In addition, QLT prevented the accumulation of collagen in the lungs in a dose-dependent way, with the high dose being more effective (Fig. 1a). Additionally, QLT treatment decreased the pulmonary collagen deposition area (Fig. 1b,c). The model group’s lung tissue contains significantly more hydroxyproline than the normal group did. QLT treatment resulted in a dose-dependent decrease in hydroxyproline content (Fig. 1d). The results discussed above show that QLT could effectively reduce PF (Fig. 1).

Figure 1
figure 1

Therapeutic effect of QLT in PF mice. (a) HE staining was used to indicate the morphology of pulmonary tissue (400 × magnification). (b) Masson staining was used to indicate collagen deposition in pulmonary tissue (400 × magnification). (c) The area percentage of blue collagen fibers in Masson pathological sections. (d) The level of hydroxyproline in pulmonary tissue. (n = 3; data are expressed as mean ± SD. ∗P < 0.05, compared with Model group).

Full size image

QLT improved the pulmonary function of PF mice

As a necessary examination method for respiratory diseases, pulmonary function could be used as one of the diagnostic methods of PF. Quasi-static lung compliance (Cchord), mean mid-expiratory flow (MMEF), peak expiratory flow (PEF), 50 ms first expiratory volume/forced vital capacity (FEV 50/FVC), functional residual capacity (FRC) and total lung capacity (TLC) reflect the pulmonary function severity of PF. The results show that compared with model group, QLT significantly improved Cchord, MMEF, PEF, FEV 50/FVC, FRC and TLC value with dose-dependent, indicated that QLT improved pulmonary function in PF mice. (Fig. 2).

Figure 2
figure 2

Effects of pulmonary function in each group. (a) Cchord: an index reflecting alveolar compliance and expansibility, representing the effect of changes in thoracic pressure on lung volume. It also reflects pulmonary tissue elasticity and airway resistance. (b) MMEF: It reflects the detection index of alveolar diffusion function. (c) PEF: it mainly reflects whether the large airway is blocked. (d) FEV 50/FVC: it is the volume of exhaled volume after maximum deep inhalation and maximum exhalation for 50 ms in mice, Obstructive or mixed type is slightly reduced to significantly reduced. (e) FRC: The decrease indicates a reduction in alveolar function. (f) TLC: The decrease is mostly related to restrictive ventilation disorder, suggesting that it is related to PF. (n = 3; data are expressed as mean ± SD. ∗P < 0.05, ∗∗P < 0.01, compared with Model group).

Full size image

QLT reduced the inflammation and collagen deposition in the pulmonary tissue of PF mice

Collagen I (COL-I) and collagen III (COL-III) are indicators of the deposition of extracellular matrix. The mRNA relative expression levels of COL-I and COL-III in the pulmonary tissue were increased in the model group compared to the control group. The mRNA levels of COL-I and COL-III were decreased in the pulmonary tissue of QLT treatment PF mice, indicating that QLT decreased the extracellular matrix deposition in PF animals. We also examined the mRNA levels of TGF-β, TNF-α, and α-smooth muscle actin (α-SMA) in lung tissue. TGF- is regarded as a major factor in the promotion of fibrosis, while TNF- is a critical element in the promotion of inflammation and fibrosis. α-SMA is a marker protein for the transformation of fibroblasts into myofibroblasts. The results confirmed that after the treatment with QLT, the mRNA levels of α-SMA, TGF-β and TNF-α were significantly down-regulated in lung, comparing with that of the model group (Fig. 3a).

Figure 3
figure 3

Effects of inflammation and collagen-related indexes in each group. (a) The relative expression level of COL-I, COL-III, α-SMA, TGF-β, and TNF-α mRNA levels in pulmonary tissues. (b) The location and expression levels of COL-I and COL-III in pulmonary tissues were detected by using an immunofluorescence assay. (c) The protein levels of α-SMA, TGF-β, and TNF-α were detected by western blot. (d) The quantification and statistical analysis of (b–d). (n = 3; data are expressed as mean ± SD. ∗P < 0.05, ∗∗P < 0.01, compared with Model group).

Full size image

To further confirm the influence of inflammation and collagen deposition level of QLT, the protein level of COL-I, COL-III, α-SMA, TGF-β, and TNF-α was evaluated. The results showed that the protein level of COL-I and COL-III in the pulmonary tissue of the model group was increased when compared with the control group and was decreased in the QLT treatment group when compared with the model group (Fig. 3b,d). Meanwhile, the protein level of α-SMA, TGF-β, and TNF-α was determined by ELISA and Western Blot. The results demonstrated that QLT decreased the protein level of α-SMA, TGF-β, and TNF-α in the pulmonary tissue of PF mice, and the high dose was more effective (Fig. 3c,d). These results suggested that QLT efficiently down-regulation inflammation and collagen deposition of PF.

QLT interfere in inflammation and collagen deposition in PF mice through IL-17 signal pathway

By sequencing the transcriptome of pulmonary tissue in the model and control group, 94 meaningful differential Expressed Genes (DEGs) were obtained after the comparison of the two groups. 72 DEGs were up-regulated and 22 were down-regulated in the model group (Fig. 4a,b). Through analyzing in database Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG), we found that the IL-17 signal pathway was important to PF (Fig. 4c). And in these two pathways, c–c motif chemokine ligand 12 (CCL12), c-x-c motif chemokine ligand 5 (CXCL5), fos-like antigen 1 (FOSL1), matrix metalloproteinase-9 (MMP9), and amphiregulin (AREG) were enriched with fold change (Fig. 4d).

Figure 4
figure 4

IL-17 signal pathway is prominent in the development of pulmonary fibrosis and the influence of QLT on IL-17 signal pathway40. (a) Heat map of differential genes clustering in pulmonary tissues. (b) Volcano plot distribution of PM 2.5 differential genes cluster heat map in pulmonary tissues. (c) KEGG analysis bubble diagram of differential genes in pulmonary tissue (X-axis represents the P-value of the enrichment factor, and the Y-axis represents the names of the 12 pathways with significant differences. The size of the dots represents the number of target genes, and the color of the dots represents the range of the false discovery rate (FDR), which represents the ratio of target genes of a specific pathway to the number of all annotated genes in that pathway). (d) The 5 differential genes in pulmonary tissue were enriched into the genes table of IL-17 signal pathway.

Full size image

By sequencing the transcriptome of pulmonary tissue in the model and to confirm the role of the IL-17 pathway in PF mice and the influence of the related genes of QLT, the mRNA level of IL-17, CCL12, FOSL1, MMP9, CXCL5, and AREG in pulmonary tissue was determined. The results showed that compared with the control group, the relative mRNA expression levels of IL-17, CCL12, FOSL1, MMP9 CXCL5, and AREG were significantly upregulated in the model group. Compared with the model group, the relative mRNA expression levels of IL-17, CCL12, FOSL1, MMP9, CXCL5, and AREG in the QLT group was significantly down-regulated, indicating that QLT reduced the expression of genes that related to IL-17 signal pathway (Fig. 5a). To further study, the protein levels of IL-17, CCL12, FOSL1, MMP9, CXCL5, and AREG were measured. Compared with the model group, the expression levels of IL-17, CCL12, FOSL1, MMP9, CXCL5 and AREG were much higher than those of the control group, while the protein levels of IL-17, CCL12, FOSL1, MMP9, CXCL5 and AREG were significantly decreased in the QLT group (Fig. 5b). These results suggested that QLT efficiently inhibited the IL-17 signal pathway (Figs. 4, 5).

Figure 5
figure 5

The influence of QLT on IL-17 signal transduction pathway. qRT-PCR was used to verify the mRNA levels of (a) IL-17, (b) CCL12, (c) FOSL1, (d) MMP9, (e) CXCL5 and (f) AREG in pulmonary tissues. Elisa was used to verify the protein levels of (g) IL-17, (h) CCL12, (i) FOSL1, (j) MMP9, (k) CXCL5 and (l) AREG in pulmonary tissues. The data shown are Mean ± SEM of 3 independent experiments. (n = 3; data are expressed as mean ± SD. ∗P < 0.05∗∗P < 0.01, compared with Model group).

Full size image

Discussion

The main pathological feature of PF is the acute inflammatory reaction of the lower respiratory tract at the early stage, accompanied by pathological proliferation and transformation of a large number of fibroblasts, resulting in the deposition of extracellular matrix (ECM) components in alveoli and stroma at the later stage. The excessive repair of fibrous tissue leads to the disorder of pulmonary tissue structure, alveolar injury, and collagen deposition, which eventually leads to PF3,41. The incidence rate of PF is high in middle-aged and elderly people. PF is mostly the pathological result of respiratory diseases, and also one of the common complications of COVID-19 patients. The accumulation of inflammatory cells and the release of cytokines increase collagen fibers, resulting in pulmonary tissue remodeling, reduction of alveolar number, deformation, atresia, and loss of pulmonary function, which are the main pathological changes of PF42,43. Previous research found that Yifei Sanjie Recipe alleviated pulmonary fibrosis by reducing the phosphorylation level of phosphatidylinositol3-kinase (PI3K) and protein kinase B (AKT), upregulating the expression of autophagy marker protein, enhancing autophagy, reducing the content of HYP and the expression of COL-I and COL-III in pulmonary tissue38. Further study indicated that curcumin and curcumol reduced fibroblasts α-SMA expression and decreased the contents of HYP and COL-I/III, which could reduce collagen synthesis. Curcumin and curcumol increased the expression levels of Beclin1, recombinant autophagy-related protein 7 (ATG7), and microtubule-associated protein 1 light chain 3B-II (Lc3b-II), promoted the formation of autophagy bodies, and activate fibroblast autophagy44. Previous report45 also found that Panax notoginseng saponins down regulated the expression of fibrosis related factors, reduced collagen fiber deposition and alleviate bleomycin induced pulmonary fibrosis in mice. Through HPLC experiments, we found that the main chemical components of QLT include Salidroside and ginsenoside Rg1 (Rg1) play an important role in anti-inflammatory and anti-fibrosis46 (Fig. S1). In this study, the pathological section results showed that there was a large infiltration of inflammatory cells in the lung tissue and an enlarged alveolar space in the PF model group. Meanwhile, the expression level of hydroxyproline, one of the main components of collagen deposition, was significantly increased. After the administration of QLT, the lung tissue was repaired with a significant decrease in the expression level of hydroxyproline, indicating that QLT could reduce the deposition of collagen and inhibit the expression of hydroxyproline. These results suggest that QLT has the effect of repairing the pathological changes in PF.

Pulmonary function examination is one of the necessary examinations for respiratory diseases and is mainly used to detect the patency of respiratory tract and the size of lung volume. It is of great value for detecting lung diseases, evaluating the severity and prognosis of diseases, and evaluating the efficacy of drugs or other treatment methods. This study showed that compared with PF model group, taking QLT could improve Cchord, MMEF, PEF, FEV50/FVC, FRC and TLC (P < 0.05), and improved pulmonary function, which is consistent with relevant research reports on pulmonary function47.

Inflammatory factors could repeatedly mediate the injury and repair of alveolar cells48. In this process, fibroblasts migrate go through the damaged basement membrane, proliferate and transform into myofibroblasts49. Large amounts of inflammatory and fibrotic factors produced by myofibroblasts are released into the extracellular matrix (ECM)50. These factors lead to the pathological processes such as cell structure remodeling, airway wall structure destruction, basement membrane thickening and interstitial hyperplasia, and resulting in pulmonary fibrosis, finally51. In process of ECM formation, TGF-β has the activity to induce fibroblasts divided to myofibroblasts and specifically promotes the secretion of α-SMA and plays an important role in formation of pulmonary fibrosis52. In addition, collagen I/ III secreted by myofibroblasts also promote ECM deposition and accelerate the progress of pulmonary fibrosis53,54. In this study, the expression of fibrosis related factors was detected. The results showed that QLT administration group significantly reduced the mRNA and protein expression level of TGF-β, α-SMA, COL-I, COL-III and TNF-α in pulmonary tissue of model mice. It indicated that QLT inhibited the activation of TGF-β, α-SMA and TNF-α, reduced pulmonary inflammatory response and collagen deposition, to delay pulmonary fibrosis.

Transcriptome sequencing is a high-throughput sequencing of the sum of all RNA that could be transcribed by a specific cell in a certain functional state55,56. In this study, the high-throughput sequencing of the transcriptome of the pulmonary tissue of mice in control group and model group was used to explore the relevant mechanism of PF. Through transcriptome sequencing, the differentially expressed genes were found, and the KEGG signal pathway were enriched and analyzed. We found that the differentially expressed genes were involved in a variety of biological processes of the body, especially the regulation of the immune system, signal transduction pathway. Through the calculation of FDR and P value, we ranked the pathways with significant differences. In these pathways, we found that IL-17 signal pathway was important to PF in this study.

IL-17 is an early promoter of T cell and induces inflammatory response. After IL-17 binds to the IL-17 receptor, IL-17 plays its biological activity through the pathway and effectively mediates the inflammatory response in tissues and cells. Previous studies57 have reported that the IL-17-driven signaling pathway plays a critical role in cell survival and tissue growth. Aberrant signaling of IL-17 implicates the pathogenesis of several autoimmune diseases, including idiopathic pulmonary fibrosis, acute lung injury, chronic airway disease, and cancer58. Literature research on the enrichment gene of the IL-17 signaling pathway in the first place showed that CCL12 chemokine produced by macrophages and epithelial cells is a fibrogenic medium, and CCL12 could promote the development of fibrosis59,60,61. Pena-Philippides et al.62 reported that CCL12 and CXCL5 cytokine expression affect the secretion of IL-17. FOSL1 could regulate biological behaviors such as proliferation, apoptosis, and migration of various cells, which is closely related to the inflammatory signal pathway63. A previous study of hepatocyte inflammation and immune response also found that the FOSL1 gene, identified based on bioinformatics techniques, is one of the central targets of action of the IL-17 signaling pathway64. MMP9, a member of the MMPs family, plays an important role in collagen hydrolysis, and they can promote collagen hydrolysis in the myocardial interstitium. TIMP1 and TIMP2, specific inhibitory molecules of MMPs, can bind to MMP molecules and reduce their hydrolytic activity, favoring collagen deposition, and suggesting that the IL-17 gene can disrupt the MMPs/TIMPs balance65,66. The previous reports indicated that IL-17 stimulates the migration of carotid artery vascular smooth muscle cells in an MMP-9-dependent manner67,68. CXCL5 chemokine is a member of the CXC chemokine family, produced by various cells, and has strong granulocyte chemotaxis69. As component of the inflammatory environment, CXCL5 has an important role in tumorigenesis, invasion, metastasis, and progression70. Previous studies have reported that IL-17 can promote inflammation and cancer development by inducing the production of factors such as CXCL571. AREG can be secret by various cells, which can cause the proliferation and differentiation of fibroblasts and protect pulmonary tissue by activating the EGFR signaling pathway to inhibit TNF-α and mediating the apoptotic signaling pathway to reduce damage to alveolar epithelial cells72,73. Previous studies have reported that AREG, a target gene of IL-17, promotes the development of keratin-forming cell proliferation74. Our studies indicated that QLT reduced the levels of IL-17, CCL12, CXCL5, FOSL1, MMP9, and AREG, which are inflammation and fibrosis-related genes in the IL-17 signal pathway.

Conclusion

In this study, we have confirmed the role of QLT in the prevention and treatment of pulmonary fibrosis and revealed the underlying mechanisms of QLT. The results suggest that QLT can improve pulmonary fibrosis in multiple ways, and the IL-17 signaling pathway is likely to be the most potential target of QLT. Our study provides a new strategy for the clinical treatment of PF.